Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Doriana Gramegna, M.D.

Concepts (60)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Doriana Gramegna's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Doriana Gramegna has written about over time.
Anemia, Hemolytic, Autoimmune, 1 publications between 2018 and 2018, average publication date June 2018. Leukemia, Promyelocytic, Acute, 1 publications between 2018 and 2018, average publication date August 2018. Fusion Proteins, bcr-abl, 1 publications between 2019 and 2019, average publication date February 2019. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 1 publications between 2019 and 2019, average publication date February 2019. Benzoates, 1 publications between 2019 and 2019, average publication date March 2019. Hydrazines, 1 publications between 2019 and 2019, average publication date March 2019. Purpura, Thrombocytopenic, Idiopathic, 1 publications between 2019 and 2019, average publication date March 2019. Receptors, Fc, 1 publications between 2019 and 2019, average publication date March 2019. Thrombopoietin, 1 publications between 2019 and 2019, average publication date March 2019. Invasive Pulmonary Aspergillosis, 1 publications between 2019 and 2019, average publication date May 2019. Leukemia, Myeloid, Acute, 2 publications between 2019 and 2020, average publication date January 2020. Hematopoietic Stem Cell Transplantation, 3 publications between 2019 and 2022, average publication date October 2020. Hodgkin Disease, 1 publications between 2021 and 2021, average publication date June 2021. Sarcopenia, 1 publications between 2021 and 2021, average publication date June 2021. Transplantation, Autologous, 2 publications between 2020 and 2022, average publication date July 2021. Core Binding Factor Alpha 2 Subunit, 1 publications between 2022 and 2022, average publication date April 2022. Myeloproliferative Disorders, 1 publications between 2022 and 2022, average publication date April 2022. Neoplasms, Second Primary, 1 publications between 2022 and 2022, average publication date April 2022.

To see the data from this visualization as text, click here.
Gramegna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (60)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.